NIH-funded research Fellowship grant

Identifying new blood markers for cognitive aging and Alzheimer's disease

Official title: Utilizing Plasma Proteomics to Identify Novel Biomarkers of Cognitive Aging

Funded at Vanderbilt University · NIH-10995274 · Data updated 2026-11-12

This study is looking at blood samples from older adults to find new proteins that might help predict cognitive decline and Alzheimer's disease, with the hope of improving our understanding of these conditions and finding better treatments.

More Aging research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionVanderbilt University
NIH-funded
Lab location1 site (Nashville, UNITED STATES)
Project startDecember 1, 2023
Project endNovember 30, 2027
Funding year2025
Award (this year)$34,296
NIH project number5F30AG085905-02
Project IDNIH-10995274 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are adults aged 65 and older, particularly those showing early signs of cognitive decline or with vascular risk factors.

Less likely to help

Patients under the age of 65 or those without any cognitive impairment or vascular risk factors may not benefit from this research.

What this research studies

This research investigates the role of plasma proteomics in identifying novel biomarkers that could predict cognitive aging and Alzheimer's disease. By analyzing blood samples from older adults, the study aims to uncover specific proteins associated with cognitive decline, particularly focusing on the interplay between Alzheimer's pathology and vascular dysfunction. The goal is to develop a better understanding of how these factors contribute to cognitive impairment and to identify potential new targets for treatment. Patients may be involved in providing blood samples and participating in assessments of cognitive function over time.

Why it matters

Potential benefit: If successful, this research could lead to earlier detection and more effective interventions for cognitive decline in older adults.

How similar studies have gone: Previous research has shown promise in using proteomics to identify biomarkers for various diseases, suggesting that this approach could yield valuable insights for cognitive aging as well.

Where this research is happening

  • Vanderbilt University
    Nashville, United States
    Active

Researchers

  • Principal investigator: Adegboye, Hailey — Vanderbilt University
  • Study coordinator: Adegboye, Hailey

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.